Skip to main content

Chronic Lymphocytic Leukemia (CLL): Diagnosis, Treatment and Side Effects Management

Recorded on March 30, 2020

Click Here to Participate

Format: Recorded Webinar
CE Credits available until: October 31, 2021

 

Target Audience

Nurse practitioners, nurses, and oncology social workers involved in the care of patients with chronic lymphocytic leukemia (CLL)

Course Content Level for Social Workers: Intermediate and Advanced      
 

Description

This webinar will provide a basic overview of chronic lymphocytic leukemia (CLL): focusing on strategies for diagnosis and patient management. Risk assessment, treatment options, the role of various members of the healthcare team in addressing treatment goals, guidance for patients and caregivers in treatment decision making, as well as resources for patients, caregivers, and healthcare providers will be discussed. 
 

Learning Objectives

At the conclusion of this program, participants will be able to:

  • Describe the various types and subtypes of chronic lymphocytic leukemia (CLL)
  • Identify tests used to diagnose disease and monitor treatment of CLL
  • Explain the overarching goals of treatment for the types of CLL
  • Explain approved and emerging treatment options for CLL, including stem cell transplantation, and the role of clinical trials.
  • Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for CLL
  • Describe the roles of the pharmacist, the nurse, and the social worker in managing patients with CLL

 

Faculty

William G. Wierda, MD, PhD
Professor of Medicine
Section Head – CLL
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Deborah McCue, PharmD, BCOP
Clinical Pharmacy Manager
Division of Pharmacy
The University of Texas MD Anderson Cancer Center
Houston, TX

Jackie Broadway-Duren, DNP, APRN, FNP-BC
Family Nurse Practitioner
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
 

Continuing Education

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.25 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/17-12/14/2020. Social workers completing this course receive 1.25 continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.25 clinical CE contact hours for this activity.

Participants must attend the free webinar in its entirety, submit the online evaluation form, and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.

Providers

This program is provided by The Leukemia & Lymphoma Society.

 

Click Here to Participate

Participants gain access to the webinar via the registration button above.

To view system requirements please visit https://llsce.org/system-requirements.

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at infocenter@LLS.org.

 



< Back to Continuing Education